Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$118.4K
4.27K shares
What this filing means
ZANTE GREG plans to sell 4.27K shares of VIKING THERAPEUTICS, INC. valued at approximately $118.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/3/2025ACC: 0001950047-25-004829
Officer· Chief Financial Officer
Since Jan 2021
4.27K
Shares to sell
$118.4K
Approx. market value
4.27K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
7/2/2025
4.27KTotal acquired4.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/2/2025 | Restricted stock vesting under a registered plan Not Applicable | 4.27K | — |
| Total | 4.27K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.27K
Market value
$118.4K
7/3/2025
Total
Units
4.27K
Value
$118.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/3/2025 | 4.27K | $118.4K | NASDAQ | Planned |
| Total | 4.27K | $118.4K | ||